Wetherby Asset Management Inc Zai Lab LTD Transaction History

Wetherby Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $147,022 - $281,752	-2,678 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $105 - $178	1 Added 0.04%	2,678 $282,000
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $4,503 - $6,480	36 Added 1.36%	2,677 $474,000
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $23,612 - $35,849	187 Added 7.62%	2,641 $352,000
Q4 2020 Feb 11, 2021	BUY	$81.94 - $135.34 $201,080 - $332,124	2,454 New	2,454 $332,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wetherby Asset Management Inc with notifications on news.